Harvard Bioscience (HBIO) Debt to Equity (2008 - 2026)
Harvard Bioscience (HBIO) debt to equity from Dec 31, 2008 to Mar 31, 2026. The current Harvard Bioscience (HBIO) debt to equity is 360.30%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Harvard Bioscience (HBIO)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 261.25% | +347.72% |
| 2024 | 58.35% | +15.74% |
| 2023 | 50.42% | -22.69% |
| 2022 | 65.22% | +11.89% |
| 2021 | 58.29% | -7.45% |
| 2020 | 62.98% | N/A |
| 2020 | 62.98% | +2.64% |
| 2019 | 61.35% | N/A |
| 2019 | 61.35% | -11.29% |
| 2018 | 69.16% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 11.10% | -29.51% |
| 2016 | 15.75% | -25.35% |
| 2015 | 21.10% | +22.43% |
| 2014 | 17.23% | -17.56% |
| 2013 | 20.90% | +68.20% |
| 2012 | 12.43% | -27.19% |
| 2011 | 17.07% | -14.47% |
| 2010 | 19.96% | N/A |
| 2009 | 0.00% | N/A |
| 2008 | 0.00% | N/A |
Comparison Harvard Bioscience (HBIO) debt to equity with competitors
Harvard Bioscience (HBIO) debt to equity is 360.30%.